MedTrace Logo

Effect of Topical and Oral Diclofenac on Pain Related to Intravitreal Injections

NCT02837770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2017-01-10

No results posted yet for this study

Summary

The analgestic efffect of Diclofenac Sodium 0.1% Eye Drops and a combination of Diclofenac Sodium 0.1% Eye Drops and oral Diclofenac Sodium sustained-release 75mg tablets on pain related to intravitreal injections will be evalutated.

Pain perception will be assessed by the Short Form of the McGill Pain Questionnaire.

Conditions

Interventions

DRUG

Diclofenac Eye Drops

One drop of Diclofenac 0.1% will be instilled 45' prior to the IVI.

DRUG

Pacebo pill

Pacebo pill will be administered 4 hours before the IVI.

DRUG

Oral Diclofenac

One Diclofenac Sodium sustained-release 75mg tablet administered per os 4 hours prior to the IVI.

DRUG

Diclofenac Eye Drops

One drop of Diclofenac 0.1% will be instilled 45' prior to the IVI.

DRUG

Pacebo pill

Pacebo pill will be administered 4 hours before the IVI.

DRUG

Artificial Tears

One drop Artificial Tears will be instilled 45' prior to the IVI.

Sponsors & Collaborators

  • University Hospital of Patras

    lead OTHER

Principal Investigators

  • Constantine Georgakopoulos, MD, Phd · Associate Professor of Ophthalmology, Medical School, University of Patras, Greece

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02837770 on ClinicalTrials.gov